Skip to main content
. 2016 Mar 25;7(17):24604–24622. doi: 10.18632/oncotarget.8360

Figure 9. The antitumor efficacy in glioma-bearing mice after treatments with varying formulations.

Figure 9

Notes: (A) MRI images of brain tissues; (B) Nissl staining of tumor masses; (C) Immunohistochemical staining for CD133 on the brain glioma sites; (D) Kaplan-Meier survival curves. a. Blank control; b. Vinorelbine liposomes; c. Vinorelbine plus tetrandrine liposomes; d. VAP-modified targeting vinorelbine liposomes; e. PEI-modified targeting vinorelbine liposomes; f. Multifunctional targeting vinorelbine plus tetrandrine liposomes.